Hello, folks, and how are you all feeling today? I hope, healthy, happy and ready to take on the day.I just came from visiting NATAP , a website that pretty much is like an online library, with a database of information including current news articles and comprehensive research on the development of promising new HCV medications.
Today, the site offered information on J&J's patient assistance program for Simeprevir (Olysio)
The program will help people who are interested in treating with simeprevir, but do not have prescription coverage and the financial means to do so.
Remember, patients can turn over the enrollment process to their healthcare providers.
To find out more about eligibility, requirements, and restrictions, begin here.
No comments:
Post a Comment